A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
Part of paid clinical trials in Glendale, Arizona.
- Sponsor
- Janssen Research & Development, LLC
- Study ID
- NCT04991753
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placebo — OTHERPlacebo infusion will be administered intravenously.
- Nipocalimab — DRUGNipocalimab infusions will be administered intravenously.
Study Details
The purpose of this study is to evaluate the efficacy and safety of nipocalimab versus placebo in participants with moderate to severe active rheumatoid arthritis (RA).
Key Dates
- Start date
- Oct 14, 2021
- Status verified
- Aug 2025
- Primary completion
- Aug 10, 2022
- Completion
- Aug 10, 2022
Study Design
- Enrollment
- 53 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Group 1: PlaceboParticipants will receive placebo intravenously (IV) every 2 weeks (q2w) through Week 10 along with standard-of-care background therapy.
- Experimental: Group 2: NipocalimabParticipants will receive nipocalimab IV q2w through Week 10 along with standard-of-care background therapy.
Primary Outcome Measure
Change From Baseline in Disease Activity Index Score 28 Using C-reactive Protein (DAS28-CRP) at Week 12 [ Time Frame: Baseline (Week 0), Week 12 ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Associates PC | Glendale | Arizona | 85306 | - |
| Arizona Arthritis & Rheumatology Research, PLLC | Mesa | Arizona | 85210 | - |
| Arizona Arthritis & Rheumatology Research, PLLC | Tucson | Arizona | 85704 | - |
| Desert Medical Advances | Palm Desert | California | 92260 | - |
| Arthritis Care and Research Center Inc.: Smitha Reddy, MD | Poway | California | 92064 | - |
| TriWest Research Associates, LLC | San Diego | California | 92108 | - |
| Inland Rheumatology Clinical Trials, Inc. | Upland | California | 91786 | - |
| DJL Clinical Research, PLLC | Charlotte | North Carolina | 28210 | - |
| STAT Research, Inc. | Vandalia | Ohio | 45377 | - |
| Low Country Rheumatology PA | Summerville | South Carolina | 29486 | - |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | - |
| Accurate Clinical Research, Inc. | Houston | Texas | 77089 | - |
| Southwest Rheumatology Research LLC | Mesquite | Texas | 75150 | - |
Related coverage on Hipa.ai
- Nipocalimab Phase 2 RA Trial Shows Higher ACR20 Response Than PlaceboNipocalimab · Aug 22, 2025 · ClinicalTrials.gov
Find similar trials in Glendale, AZ
By condition
By research site
Arizona Arthritis & Rheumatology Associates PC· Glendale, AZArizona Arthritis & Rheumatology Research, PLLC· Mesa, AZArizona Arthritis & Rheumatology Research, PLLC· Tucson, AZDesert Medical Advances· Palm Desert, CAArthritis Care and Research Center Inc.: Smitha Reddy, MD· Poway, CATriWest Research Associates, LLC· San Diego, CA
Related Studies
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio
- R-2487 in Patients With Rheumatoid ArthritisPHASE1 · Recruiting · Rise Therapeutics LLC · San Diego, California
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Glendale, Arizona
- A Study of BMS-986528 in Participants With Refractory Rheumatoid ArthritisPHASE1/PHASE2 · Not Yet Recruiting · Bristol-Myers Squibb · Aurora, Colorado